Q32 Bio Inc. Insider Trading

QTTB

Last 12 months

Insiders bought $15M and sold 505K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. CEO Jodie Pope Morrison sold 78K on Dec 2, 2025, 19% of their stake, outside a plan.

Net open-market

+$14.5M

1 buy · 11 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 3

executives and directors

Last open-market buy

May 2026

May 28, 2026

Get an email when QTTB's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 6	Jodie Pope Morrison CEO	SoldNo plan	3,221	$8.32	27K	0.9%	Form 4
Oct 6	Shelia M. Violette Chief Scientific Officer	SoldNo plan	917	$8.32	8K	0.6%	Form 4
Oct 6	Lee Kalowski CFO and President	SoldNo plan	1,301	$8.32	11K	0.9%	Form 4
Aug 25	Lee Kalowski CFO and President	SoldNo plan	3,972	$16.56	66K	2.8%	Form 4
Aug 25	Jodie Pope Morrison CEO	SoldNo plan	9,845	$16.56	163K	2.8%	Form 4
Aug 25	Shelia M. Violette Chief Scientific Officer	SoldNo plan	2,798	$16.56	46K	1.7%	Form 4
May 28	Diyong Xu Director	Bought 2 parts	1,875,000	$8.00 average	$15M	New	Form 4
May 28	Orbimed Capital GP VII LLC Large holder	Bought 2 parts	1,875,000	$8.00 average	$15M	New	Form 4
Feb 25	Lee Kalowski CFO and President	SoldNo plan	3,995	$4.51	18K	10%	Form 4
Feb 25	Jodie Pope Morrison CEO	SoldNo plan	9,896	$4.51	45K	10.0%	Form 4
Feb 25	Shelia M. Violette Chief Scientific Officer	SoldNo plan	2,815	$4.51	13K	3.0%	Form 4
Dec 2, 2025	Jodie Pope Morrison CEO	SoldNo plan	22,506	$3.46	78K	19%	Form 4
Dec 2, 2025	Lee Kalowski CFO and President	SoldNo plan	9,072	$3.46	31K	19%	Form 4
Aug 26, 2025	Jodie Pope Morrison CEO	SoldNo plan	10,494	$1.80	19K	8.0%	Form 4
Aug 26, 2025	Shelia M. Violette Chief Scientific Officer	SoldNo plan	2,990	$1.80	5K	3.1%	Form 4
Aug 26, 2025	Lee Kalowski CFO and President	SoldNo plan	4,240	$1.80	8K	8.0%	Form 4

Oct 6No plan
Jodie Pope Morrison
CEO · sold 3,221 at $8.32
27K
0.9% of stake
Oct 6No plan
Shelia M. Violette
Chief Scientific Officer · sold 917 at $8.32
8K
0.6% of stake
Oct 6No plan
Lee Kalowski
CFO and President · sold 1,301 at $8.32
11K
0.9% of stake
Aug 25No plan
Lee Kalowski
CFO and President · sold 3,972 at $16.56
66K
2.8% of stake
Aug 25No plan
Jodie Pope Morrison
CEO · sold 9,845 at $16.56
163K
2.8% of stake
Aug 25No plan
Shelia M. Violette
Chief Scientific Officer · sold 2,798 at $16.56
46K
1.7% of stake
May 28
Diyong Xu
Director · bought 1,875,000 at avg $8.00
$15M
New position
May 28
Orbimed Capital GP VII LLC
Large holder · bought 1,875,000 at avg $8.00
$15M
New position
Feb 25No plan
Lee Kalowski
CFO and President · sold 3,995 at $4.51
18K
10% of stake
Feb 25No plan
Jodie Pope Morrison
CEO · sold 9,896 at $4.51
45K
10.0% of stake
Feb 25No plan
Shelia M. Violette
Chief Scientific Officer · sold 2,815 at $4.51
13K
3.0% of stake
Dec 2, 2025No plan
Jodie Pope Morrison
CEO · sold 22,506 at $3.46
78K
19% of stake
Dec 2, 2025No plan
Lee Kalowski
CFO and President · sold 9,072 at $3.46
31K
19% of stake
Aug 26, 2025No plan
Jodie Pope Morrison
CEO · sold 10,494 at $1.80
19K
8.0% of stake
Aug 26, 2025No plan
Shelia M. Violette
Chief Scientific Officer · sold 2,990 at $1.80
5K
3.1% of stake
Aug 26, 2025No plan
Lee Kalowski
CFO and President · sold 4,240 at $1.80
8K
8.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch QTTB, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with QTTB

CompareIntrinsic value

TNGXTango Therapeutics Inc.

$23.18+0.04%40

SIGASiga Technologies Inc.

$3.15+1.29%20

AQSTAquestive Therapeutics Inc.

$3.80-2.06%10

GOSSGossamer Bio Inc.

$9.40+1.29%10

PRTAProthena Corporation plc

$8.39+2.19%25

NKTRNektar Therapeutics Inc.

$38.48+1.91%25

CARMCarisma Therapeutics Inc.

$0.00+100.00%60

OCULOcular Therapeutix Inc.

$7.14+4.69%10

Held by ETFs

QTTB is in 4 US ETFs. The largest of them, with QTTB's weight in each:

Spot a number that looks wrong? Check it in QTTB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing QTTB

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.